263 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Second Genome Competitors or Alternatives

Second Genome's top competitors include Seres Therapeutics, Rebiotix and Vedanta.

Unlock 9 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Second Genome's company profile

Karim Dabbagh

President & CEO

83/100
25 - 100
$68.7M
$100K - 5M
  • $68.7M
    $100K - 5M
  • 25 - 100
    $68.7M
  • $100K - 5M
  • 83/100
  • 25 - 100
  • $68.7M
  • $100K - 5M
View ProfileView
1
Second Genome's Competitor - Seres Therapeutics logo

Eric D. Shaff

President & CEO

87/100
330
$617.9M
$126.3M
  • $617.9M
    $126.3M
  • 330
    $617.9M
  • $126.3M
  • 87/100
  • 330
  • $617.9M
  • $126.3M
View ProfileView
2
Second Genome's Competitor - Rebiotix logo

Lee Jones

President & CEO

89/100
25 - 100
$40M
$100K - 5M
  • $40M
    $100K - 5M
  • 25 - 100
    $40M
  • $100K - 5M
  • 89/100
  • 25 - 100
  • $40M
  • $100K - 5M
View ProfileView
3
Second Genome's Competitor - Vedanta logo

Bernat Olle

Co-Founder & CEO

84/100
100 - 250
$427.1M
$5M - 25M
  • $427.1M
    $5M - 25M
  • 100 - 250
    $427.1M
  • $5M - 25M
  • 84/100
  • 100 - 250
  • $427.1M
  • $5M - 25M
View ProfileView
4
Second Genome's Competitor - MetaboGen logo

Sara Malcus

CEO

70/100
25 - 100
$1.6M
$5M - 25M
  • $1.6M
    $5M - 25M
  • 25 - 100
    $1.6M
  • $5M - 25M
  • 70/100
  • 25 - 100
  • $1.6M
  • $5M - 25M
View ProfileView
5
Second Genome's Competitor - 4D pharma logo

Duncan Peyton

CEO

89/100
95
$97.4M
$ < 1M
  • $97.4M
    $ < 1M
  • 95
    $97.4M
  • $ < 1M
  • 89/100
  • 95
  • $97.4M
  • $ < 1M
View ProfileView
Second Genome's top 12 competitors are Seres Therapeutics, Rebiotix, Vedanta, Enterome, MetaboGen, 4D pharma, Symbiotix Biotherapies, MicroBiome Therapeutics, LLC, Metabiomics, ApoCell, Eligo Bioscience and Cognigen Corporation. Together they have raised over 1.4B between their estimated 1.1K employees. Second Genome's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 20M. Second Genome has 41 employees and is ranked 10th among it's top 10 competitors. The top 10 competitors average 92.

Second Genome VS Seres Therapeutics

Seres Therapeutics is the top competitor of Second Genome. Seres Therapeutics is a Public company that was founded in Cambridge, Massachusetts in 2010. Like Second Genome, Seres Therapeutics also operates in the Biotechnology sector. Seres Therapeutics has 289 more employees vs. Second Genome.

Second Genome VS Rebiotix

Rebiotix is seen as one of Second Genome's biggest rivals. Rebiotix was founded in Roseville, Minnesota} in 2011. Like Second Genome, Rebiotix also competes in the Biotechnology space. Compared to Second Genome, Rebiotix generates $500K less revenue.

Second Genome VS Vedanta

Vedanta is perceived as one of Second Genome's biggest rivals. Vedanta was founded in 2010, and is headquartered in Cambridge, Massachusetts. Like Second Genome, Vedanta also operates in the Biotechnology space. Vedanta generates $4.6M more revenue vs. Second Genome.

Looking for similar companies to Second Genome?

Similar Companies

Biotechnology companies in Brisbane

See 37 companies 
Biotechnology companies in San Francisco Bay Area

See 1,319 companies 
Pharmaceuticals & Biotechnology companies in Brisbane

See 54 companies 
Companies in Brisbane with revenue in $100K-5.0M range

See 1,526 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,673 companies 
Biotechnology companies in California

See 3,097 companies 
Companies in Brisbane with employees in 25-100 range

See 3,464 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,181 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,537 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Second Genome and Second Genome's Competitors

April 1, 2025Nasdaq
(RTTNews) - QIAGEN N.V. (QGEN) has unveiled the QIAprep& Plasmodium Kit along with two companion assays to enhance efforts in malaria research and moni...
April 2, 2025PR Newswire
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, A...
April 1, 2025centralcharts
NESS ZIONA, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing...
April 2, 2025Yahoo
In This Article: Qiagen ( NYSE:QGEN ) Full Year 2024 Results Key Financial Results Revenue: US$1.98b (flat on FY 2023). Net income: US$83.6m (down 76% ...

Frequently Asked Questions about Second Genome

  1. Who are Second Genome's top competitors?

    Second Genome's top 3 competitors are Seres Therapeutics, Rebiotix, Vedanta.

  2. Who is similar to Second Genome?

    Seres Therapeutics is the most similar to Second Genome. Rebiotix and Vedanta are also similar to Second Genome.

  1. Are Second Genome and Seres Therapeutics competitors?

    Yes, Seres Therapeutics is one of Second Genome’s top competitors.